Connect your AI

10x Genomics, Inc. TXG Available For Sale Securities Debt Securities Current

Available For Sale Securities Debt Securities Current at other companies

General MotorsGM

$4.62B-33.3%

SalesforceCRM

$2.9B-55.2%

Cloudflare, Inc.NET

$3.23B+88.9%

Arista NetworksANET

$9.56B+51.7%

Datadog, Inc.DDOG

$4.33B+28.6%

ServiceNowNOW

$2.48B-23.2%

Other financials

Income statement

Revenue$150.8M-2.6%

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

Market cap$4.41B+154%

Profitability

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s available for sale securities debt securities current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is 10x Genomics, Inc.'s available for sale securities debt securities current?: 10x Genomics, Inc. (TXG) reported available for sale securities debt securities current of $49.56M in Q1 2026.
How has 10x Genomics, Inc.'s available for sale securities debt securities current changed year-over-year?: 10x Genomics, Inc.'s available for sale securities debt securities current decreased by 0.6% year-over-year, from $49.84M to $49.56M.